Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD
- Berkan Kurt
- , Matthias Rau
- , Oliver Hartmann
- , Andreas Bergmann
- , Martin Reugels
- , Susanne Just
- , Florian A Wenzl
- , Julia Moellmann
- , Jens Spießhöfer
- , Andrea Milzi
- , Kinan Kneizeh
- , Kirsten Thiele
- , Mathias Hohl
- , Simina-Ramona Selejan
- , Emiel P C van der Vorst
- , Edgar Dahl
- , Jörg Schröder
- , Thomas F Lüscher
- , Nikolaus Marx
- , Michael Lehrke
- RWTH Aachen University
- SphingoTec GmbH
- Wyss Zurich (University of Zurich)
- Saarland University Hospital and Saarland University Faculty of Medicine
- Klinikum Traunstein
Research output: Contribution to journal › Original Article › peer-review